$3.380
-0.088 (-2.59%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ACRS Prediction & Forecast by Similar Chart Analysis
Alphio's ACRS stock price prediction model matches the current Aclaris Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.42 (+1.30%). The 1-week path is $3.35 (-0.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Aclaris Therapeutics, Inc. Stock?
Aclaris Therapeutics Inc is a good buy right now due to its current price of $3.83, which is significantly below analyst price targets of $10 and $13, suggesting a potential upside of over 160%. Additionally, the company has a strong cash position of $170.6 million, which can support its ongoing clinical trials and operational expenses. The main risk is its RSI of 31.387, indicating potential oversold conditions, which may lead to further price declines in the short term.
ACRS stock price ended at $3.38 on Wednesday, after losing -2.59%
Aclaris Therapeutics, Inc. (ACRS) last closed at $3.38, losing -2.59%. These facts feed the 1-day and 1-week ACRS price prediction above.
Analyst Consensus
Aclaris Therapeutics, Inc. (ACRS): 6 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Aclaris Therapeutics, Inc. (ACRS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ACRS, ranked by similarity.
Seasonality analysis for ACRS
Historically the probability of a positive October return for ACRS is 63.16%. December offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ACRS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $0.71 | $0.73 | $0.81 | -78.47% |
| Nov 2026 | $0.58 | $0.73 | $0.88 | -78.47% |
| Dec 2026 | $0.77 | $0.84 | $0.91 | -75.04% |
In 2026, Aclaris Therapeutics, Inc. (ACRS) is projected to range from $0.58 to $0.91.
Aclaris Therapeutics, Inc. 2026 monthly forecast
In Oct 2026, Aclaris Therapeutics, Inc. is projected to average $0.73, with a low of $0.71 and high of $0.81.
In Nov 2026, Aclaris Therapeutics, Inc. is projected to average $0.73, with a low of $0.58 and high of $0.88.
In Dec 2026, Aclaris Therapeutics, Inc. is projected to average $0.84, with a low of $0.77 and high of $0.91.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.